Faruqi & Faruqi, LLP is Investigating Emergent BioSolutions (EBS) on Behalf of its Shareholders
Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolutions Inc. (“Emergent BioSolutions” or the “Company”) (NYSE:EBS).
The investigation focuses on whether the Company’s Board of Directors and/or officers breached their fiduciary duties.
Request more information now by filling out the form below. There is no cost or obligation to you.
If you currently own Emergent BioSolutions stock, have continuously owned Emergent BioSolutions stock and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Nina Varindani or Christopher M. Lash toll free at (215) 277-5770 (Ext. 1413) or by sending an e-mail to firstname.lastname@example.org or email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding the Company’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.
Emergent BioSolutions Inc.
* The submission of this form does not create an attorney-client relationship.
Filed on 06/22/2021
685 Third Avenue 26th Floor
10017 New York, New York
Phone (212) 983-9330
Fax (212) 983-9331
Christopher M. Lash firstname.lastname@example.org Phone (215) 277-5770 Fax (215) 277-5771